This category includes the following tumors: diffuse astrocytoma, MYB/MYBL1 altered, angiocentric glioma, polymorphous low-grade neuroepithelial tumor of the young (PLNTY), and diffuse low-grade glioma, mitogen-activated protein kinase (MAPK) pathway altered. Here, MYBL1 is linked to diffuse astrocytoma.